• Explore /
  • Poster
  • / MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.

MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.

Abstract Poster

Authors

null

Ina Ly

Massachusetts General Hospital, Boston, MA

Ina Ly , Jonathan Cardona , Kevin Lou , Andrew Beers , Ken Chang , James Brown , David A. Reardon , Isabel Arrillaga-Romany , Deborah Anne Forst , Justin T Jordan , Eudocia Quant Lee , Jorg Dietrich , Lakshmi Nayak , Patrick Y. Wen , Ugonma Nnenna Chukwueke , Tracy Batchelor , William T. Curry , Jayashree Kalpathy-Cramer , Elizabeth Robins Gerstner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT03139916

Citation

J Clin Oncol 38: 2020 (suppl; abstr 2546)

DOI

10.1200/JCO.2020.38.15_suppl.2546

Abstract #

2546

Poster Bd #

37

Abstract Disclosures

Similar Posters

First Author: Ina Ly

First Author: Hao-Wen Sim

First Author: Phioanh Leia Nghiemphu

First Author: Evanthia Galanis